Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02744456 · ClinicalTrials.gov registry record · Early Phase 1
N-of-1 Trials for Blood Pressure Medications in Adults
A Early Phase 1 study, sponsored by Columbia University.
- Completed
- Registry status
- Early Phase 1
- Development phase
- 10
- Enrollment target
NCT02744456 is a Early Phase 1 study that has completed, run by Columbia University. The registered enrollment target is 10 participants.
The verdict
NCT02744456, a Early Phase 1 study, has completed, sponsored by Columbia University.
- COMPLETED
- Registry status
- Early Phase 1
- Development phase
- 10 participants
- Enrollment target
Study Summary
Many patients want to know which blood pressure medication is the best for them. In this study, we will test the feasibility of a new approach to determining the best blood pressure medication for individual patients by performing an N-of-1 trial in which patients will have the opportunity to test a series of 3 blood pressure medications at escalating doses while carefully measuring their blood pressure and side-effects. At the end of each of these N-of-1 trials, we will ask patients to complete a questionnaire in which they rate their level of satisfaction with this approach to learning about which is the best blood pressure medication for them.
Interventions
- DRUG Losartan
- DRUG Amlodipine
- DRUG Hydrochlorothiazide
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 10 participants |
| Start Date | 2014-08-01 |
| Est. Completion | 2017-12-31 |
| Phase | Early Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02744456
The ClinicalTrials.gov registry entry for NCT02744456 describes a study currently listed as completed, categorized as Early Phase 1. The registered enrollment target is 10 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Columbia University, which has 958 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 3 interventions - of which Losartan is the first listed.
NCT02744456 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02744456 about?
NCT02744456 is a clinical study titled "N-of-1 Trials for Blood Pressure Medications in Adults". Many patients want to know which blood pressure medication is the best for them. In this study, we will test the feasibility of a new approach to determining the best blood pressure medication for individual patients by performing an N-of-1 trial in which patients will have the opportunity to test a...
What is the current status of trial NCT02744456?
This trial is currently completed. It is a Early Phase 1 study. The enrollment target is 10 participants. The study started on 2014-08-01. Estimated completion is 2017-12-31.
What interventions are being tested in trial NCT02744456?
The interventions under investigation include: Losartan (DRUG), Amlodipine (DRUG), Hydrochlorothiazide (DRUG).
Who is sponsoring clinical trial NCT02744456?
This trial is sponsored by Columbia University, which has 958 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.